课题基金 / 基金详情

Glucose Lowering Drugs or Strategies, Major Adverse Cardiovascular Events and Heart Failure Outcomes, and Association with Weight Loss - A Meta-analysis of Large Cardiovascular Outcome Trials

Glucose Lowering Drugs or Strategies, Major Adverse Cardiovascular Events and Heart Failure Outcomes, and Association with Weight Loss - A Meta-analysis of Large Cardiovascular Outcome Trials
降血糖药物或策略、主要不良心血管事件和心力衰竭结果以及与减肥的关联 - 大型心血管结果试验的荟萃分析
批准号:
412251
负责人:
Ghosh-Swaby Olivia R
金额:
$0.07万
依托单位国家:
加拿大
项目类别:
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-09-01 至 2020-09-01

项目摘要

项目成果

Ghosh-Swaby Olivia R的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The consistency of diabetes therapies to reduce or increase cardiovascular (CV) risk such as heart failure (HF) or major adverse cardiovascular events (MACE) - stroke, heart attack, or CV death - remains unclear. We searched online research databases an
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exercise and anti-diabetic drugs to restore brain function in obesity
  • 批准号:
    437270
  • 项目类别:
    Studentship Programs
  • 资助金额:
    $10.93万
  • 财政年份:
    2020
  • 负责人:
    Ghosh-Swaby Olivia R
  • 依托单位:
Exercise and anti-diabetic drugs to restore neural stem cells, memory and mood in obesity
  • 批准号:
    439789
  • 项目类别:
    Studentship Programs
  • 资助金额:
    $7.65万
  • 财政年份:
    2020
  • 负责人:
    Ghosh-Swaby Olivia R
  • 依托单位:
海外基金